statistiche per CIVALLERO, Monica

Distribuzione geografica

Continente	#
NA - Nord America	1749
EU - Europa	607
AS - Asia	116
SA - Sud America	3
Continente sconosciuto - Info sul continente non disponibili	2
AF - Africa	1
Totale	2478

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	1743
GB - Regno Unito	326
IT - Italia	94
CN - Cina	44
UA - Ucraina	43
TR - Turchia	42
DE - Germania	38
FR - Francia	30
SE - Svezia	30
BG - Bulgaria	23
FI - Finlandia	12
IN - India	12
CA - Canada	6
JP - Giappone	6
VN - Vietnam	6
RU - Federazione Russa	5
CL - Cile	3
MY - Malesia	3
A2 - ???statistics.table.value.countryCode.A2???	2
CH - Svizzera	2
IR - Iran	2
EG - Egitto	1
ES - Italia	1
MK - Macedonia	1
NO - Norvegia	1
RO - Romania	1
TW - Taiwan	1
Totale	2478

Salva come PNG Salva come JPEG

Città	#
Fairfield	371
Southend	304
Woodbridge	235
Ashburn	156
Houston	155
Ann Arbor	128
Cambridge	117
Seattle	115
Wilmington	100
Jacksonville	82
Dearborn	78
Modena	52
San Diego	33
Izmir	27
Sofia	23
Fremont	21
Beijing	19
Eugene	19
San Giuliano Milanese	9
Falls Church	8
Norwalk	8
Dong Ket	6
Redwood City	6
Latina	5
Nanjing	4
Ottawa	4
Chicago	3
Chongqing	3
Grafing	3
Hefei	3
Kunming	3
Milan	3
Phoenix	3
Auburn Hills	2
Augusta	2
Changsha	2
Clearwater	2
Guangzhou	2
Indiana	2
Las Vegas	2
Leawood	2
Mansfield	2
Parma	2
Saint Louis	2
Shanghai	2
Ardabil	1
Atlanta	1
Bangalore	1
Baotou	1
Brindisi	1
Buffalo	1
Caravate	1
Civitanova Marche	1
Corte Franca	1
Eden Prairie	1
Formigine	1
Frattamaggiore	1
Horia	1
Jinan	1
Kagoya	1
Kish	1
Langfang	1
Meiringen	1
Minneapolis	1
Montréal	1
Mountain View	1
New York	1
Philadelphia	1
Prilep	1
Redmond	1
Saint Petersburg	1
San Jose	1
Segrate	1
Shenyang	1
Simi Valley	1
Soliera	1
Taipei	1
Taizhou	1
Toronto	1
Vancouver	1
Vennesla	1
Verona	1
Yinchuan	1
Totale	2168

Salva come PNG Salva come JPEG

Nome	#
Cell-penetrating CaCO3nanocrystals for improved transport of NVP-BEZ235 across membrane barrier in T-cell lymphoma	217
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines	187
Activity of BKM120 and BEZ235 against lymphoma cells	178
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine	173
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines	155
Calcium-Carbonate Nanocapsules Improve the Efficacy of BEZ235 in Lymphoma a Cell Line: A Promising New Technology of Drug Delivery	146
Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts	137
Rational combinations of enzastaurin with novel targeted agents for patients with B-cell non-Hodgkin's lymphoma	137
NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy	134
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases	131
The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines	128
Genomic profiling of enzastaurin-treated B cell lymphoma RL cells	126
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines.	126
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978	103
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway.	99
Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression.	85
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project	63
Survival outcomes for extranodal natural-killer T-cell lymphoma – Authors' reply	59
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination	52
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas	37
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project	28
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project	11
The Value and relevance of T-cell lymphoma registries	9
Totale	2521

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	2521
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	2521

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2016/2017	18	0	0	0	0	0	0	0	0	0	0	18	0
2017/2018	167	5	0	5	27	15	88	1	9	5	5	3	4
2018/2019	406	16	15	20	20	16	23	20	3	54	35	84	100
2019/2020	690	59	22	16	39	57	109	125	76	81	42	39	25
2020/2021	742	72	99	46	71	87	45	40	79	31	83	51	38
2021/2022	442	36	29	63	29	9	64	36	22	44	46	64	0
Totale													2521